Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins

Abstract
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 were used with MF59 adjuvant as a candidate vaccine for a phase 1 safety and immunogenicity

This publication has 13 references indexed in Scilit: